GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Windtree Therapeutics WINT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Windtree Therapeutics — daily WINT Delayed
Market value
$47
Last close × shares
Volume
677
Shares, 9 Nov 2026

About Windtree Therapeutics

Its shares trade under the ticker WINT. It has been listed since 9 August 1995. In the fiscal year to 31 December 2019, it reported revenue of $198,000 and a net loss of $27.5m. At that date it held total assets of $119.0m and shareholders' equity of $74.9m.

Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. The company is headquartered in Warrington, Pennsylvania. The firm is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The firm operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The firm's technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant, and drug delivery technologies being developed to enable non-invasive administration of aerosolized KL4 surfactant. The firm's core development program, AEROSURF (lucinactant for inhalation), is focused on improving the management of respiratory distress syndrome (RDS) in premature infants, a respiratory condition that can result in long-term respiratory problems, developmental delay and death.

Figures and description from our data supplier, not checked against the company's own report.

More about Windtree Therapeutics →

Latest on Windtree Therapeutics

Our reporting

We have not reported on Windtree Therapeutics yet.

Next results

26 Nov 2026

Due on 26 Nov 2026. Analysts expect earnings of -13500.00 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Windtree Therapeutics's ticker?

Windtree Therapeutics trades as WINT on its US listing, under ISIN US97382D6004.

What was Windtree Therapeutics's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Windtree Therapeutics next report results?

Results are expected on 26 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.